Bruno Ramalho Carvalho, Jhenifer Kliemchen Rodrigues, Jacira Ribeiro Campos, Adelino Amaral Silva, Ricardo Mello Marinho, Ana Carolina Japur de Sá Rosa e Silva
JBRA Assist. Reprod. 2014; 18 (1):16-23
Received March 03, 2014
Accepted March 19, 2014
Abstract
Malignant and cardiovascular diseases are the main causes of death in Brazil. Estimates for 2013 predict the occurrence of 189,150 new cases of cancer in Brazilian women. With advanced detection tools, patients are diagnosed and treated for cancer at a younger age and are more likely to survive. The cytotoxic action of chemotherapeutic agents and radiotherapy very frequently implies serious damage to the gonads, and consequences due to the hypoestrogenism, such as osteoporosis, infertility and premature ovarian failure, are expected. Oncofertility, then, appears as a new area of reproductive medicine, which is dedicated to the development of strategies for the reduction of therapeutic sequels in cancer survivals, ultimately aiming the maintenance of their quality of life and the possibility of biological maternity. This article aims to present an overview of possible options for female fertility preservation after cancer and future perspectives in oncofertility.
